Unlocking Value & Efficiency: Exome and Genome Sequencing as First-Line Diagnostic Tools
Fri, Dec 5
|
02:00 PM - 02:30 PM
Davidson AE
Session details:
Exome and genome sequencing are increasingly recognized as first-line diagnostic tools that shorten the diagnostic odyssey, reduce unnecessary healthcare utilization, and enable earlier, more effective clinical management for children with suspected genetic conditions.
This session will explore the evidence behind their clinical and economic value, including earlier diagnoses, improved outcomes, and better resource utilization.